author-photo

Junzheng Yang

Novartis

10

Papers

37

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

In-vitro and In-vivo pharmacology of SAF312 as a TRPV1 inhibitor for ocular surface pain

2021 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration.

2021 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Erythropoietin (EPO) overexpression induces a DME-like phenotype in the mouse retina

2019 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Overexpression of HTRA1 in mice compromises the extracellular matrix integrity in Bruch’s membrane and choroidal/retinal vasculature

2019 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
ADIPOR1 is essential for vision and its RPE expression is lost in the Mfrp rd6 mouse

2018 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (17)
Retinal degeneration and subretinal Iba1+ accumulation in complement factor H-deficient mice are associated with increased gene expression of phagocytic markers

2018 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Deletion of complement factor H is associated with accumulation of subretinal Iba-1-positive cells and retinal degeneration in aged mice

2017 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
605. Residual Cesium Chloride in AAV Vectors Purified by CsCl Gradient Centrifugation Does Not Cause Obvious Inflammation or Retinal Degeneration in C57Bl6/J Mice Following Subretinal Injection

2015 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (2)
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice.

2015 Molecular therapy. Methods & clinical development
Show All
- Source
- Cite
- Save
Citations (18)